We have located links that may give you full text access.
Telerheumatology: A technology appropriate for virtually all.
Seminars in Arthritis and Rheumatism 2016 December
BACKGROUND/PURPOSE: Telerheumatology services were developed at Dartmouth-Hitchcock Medical Center (DHMC) to bring specialty care to New Hampshire (NH) and Vermont (VT) where a large proportion of the population lives in rural areas (60%) with limited resources and access to care. We sought to learn what challenges and accomplishments our early telemedicine program has encountered since inception.
METHODS: As part of a quality improvement initiative we performed an IRB-exempt retrospective review of patients seen in the telerheumatology clinic at DHMC from October 2011 to December 2014. We also interviewed the participants; including providers, presenters, and patients regarding their experience of care. We assessed both patient and provider satisfaction with the experience.
RESULTS: Between October 2011 and December 2014, 176 patients were seen via telerheumatology between two clinical sites over the course of 244 telerheumatology patient visits. The top diagnosis for patients during the telerheumatology visits was inflammatory arthritis (n = 156, 63.9%). We found 19% of patients to be inappropriate for the visit type for the following two main reasons: the underlying diagnosis was unclear or the disease was too complex.
CONCLUSION: The use of telerheumatology has successfully increased access to specialty care in rural regions of NH and VT with good patient and provider satisfaction. While telerheumatology improved the access to specialty care, consideration should be given to selecting the appropriate patient for this visit type given that 19% of patients were deemed inappropriate. We propose a triage mechanism to ensure that patients are appropriately paired to the proper visit type in the future.
METHODS: As part of a quality improvement initiative we performed an IRB-exempt retrospective review of patients seen in the telerheumatology clinic at DHMC from October 2011 to December 2014. We also interviewed the participants; including providers, presenters, and patients regarding their experience of care. We assessed both patient and provider satisfaction with the experience.
RESULTS: Between October 2011 and December 2014, 176 patients were seen via telerheumatology between two clinical sites over the course of 244 telerheumatology patient visits. The top diagnosis for patients during the telerheumatology visits was inflammatory arthritis (n = 156, 63.9%). We found 19% of patients to be inappropriate for the visit type for the following two main reasons: the underlying diagnosis was unclear or the disease was too complex.
CONCLUSION: The use of telerheumatology has successfully increased access to specialty care in rural regions of NH and VT with good patient and provider satisfaction. While telerheumatology improved the access to specialty care, consideration should be given to selecting the appropriate patient for this visit type given that 19% of patients were deemed inappropriate. We propose a triage mechanism to ensure that patients are appropriately paired to the proper visit type in the future.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app